HopeStage
Back to all studies
CompletedNCT05535062

Comfort of a new NeuroStar brain stimulation feature

About this titleRead the official source — NCT05535062
Device studyAges 22–70United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 22 years to 70 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 7, 2022
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
Neuronetics
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 70 Years
Official registry ID
NCT05535062
Official title
Show the full official title

A Prospective, Randomized, Single Blind, Crossover Study to Evaluate Treatment Effects Associated With the NeuroStar New Treatment Feature

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Tampa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Neuronetics.

Who was this study for?

Listed age limits: 22 years to 70 years.

Want to explore more studies?

Explore studies